Pediatric nonalcoholic fatty liver disease

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Metabolic Disorders

Background:

• Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition in children.
• The increasing prevalence of childhood obesity is closely linked to the rise in pediatric NAFLD.
• Associated comorbidities include insulin resistance, hypertension, and dyslipidemia, highlighting its systemic impact.

Purpose of the Study:

• To review the current understanding of pediatric NAFLD, including its causes, diagnosis, and management.
• To emphasize the link between obesity, metabolic dysfunction, and the progression of liver disease in children.
• To highlight the importance of lifestyle modifications and potential therapeutic strategies.

Main Methods:

• Review of existing literature on pediatric NAFLD.
• Analysis of diagnostic criteria and challenges.
• Evaluation of current and emerging treatment strategies.

Main Results:

• Pediatric NAFLD is strongly associated with obesity and metabolic syndrome.
• Liver biopsy remains the gold standard for diagnosis, though non-invasive methods are improving.
• Lifestyle modifications (diet, exercise, weight loss) are the cornerstone of treatment.
• Antioxidant therapies, such as vitamin E, show promise for biopsy-proven steatohepatitis.

Conclusions:

• Pediatric NAFLD is a significant health concern requiring early detection and intervention.
• A multidisciplinary approach involving lifestyle changes is essential for managing pediatric NAFLD.
• Further research into the underlying mechanisms and novel therapeutic targets is warranted.